---
title: 'Senior Scientist, Analytical Development at Asimov'
canonical: 'https://feeny.ai/job/senior-scientist-analytical-development-asimov-boston-9r1y790704fx'
type: 'job'
last_seen: '2026-10-16'
---

# Senior Scientist, Analytical Development at Asimov

- **Company:** Asimov
- **Location:** Boston, MA
- **Compensation:** $145k–$165k
- **Employment:** full-time
- **Posted:** 2026-09-24
- **Last confirmed live:** 2026-10-16
- **Apply:** https://jobs.ashbyhq.com/asimov/2dbd4530-e961-478e-bc40-1487ca82954d

## Job description

Our mission at Asimov is to advance humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We're developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics.

We are seeking a Senior Scientist to join our Analytical Sciences team. In this role, you will lead analytical efforts to develop and optimize methods supporting the characterization of antibodies and diverse antibody formats (including bispecifics and other multispecifics, Fc-fusions, and other engineered architectures), proteins, and CGT therapeutics. You will actively collaborate with multiple teams, ensuring that your work and insights are aligned with broader program goals. You will apply your technical skills to address complex analytical challenges, continuously grow your expertise, and contribute to a culture of scientific rigor.

About the Role:

- Lead analytical development efforts for key projects, designing and implementing experiments to generate actionable results.
- Engage with cross-functional teams to share findings, raise critical analytical issues, and support aligned decision-making.
- Manage and mentor junior scientists, focusing on experimental design, problem-solving, and fostering a culture of scientific rigor.
- Ensure transparency and maintain consistent communication with project stakeholders about progress, risks, and results.
- Continuously develop and apply technical skills in analytical method development (HPLC/UPLC, MS, CE, and other protein characterization techniques) to address evolving project needs.
- Identify opportunities to improve workflows, analytical throughput, and reproducibility.

About You:

- Ph.D. in Analytical Chemistry, Biochemistry, Molecular Biology, or related field with 4+ years of relevant biopharma analytical experience, or M.S. with 7+ years of relevant experience.
- Hands-on experience in analytical method development (HPLC/UPLC, MS, CE, UV, etc.) across diverse antibody formats, with a willingness and aptitude to rapidly expand technical expertise.
- Strong understanding of antibody structural formats and how format-specific architecture (bispecifics/multispecifics, Fc-fusions, biosimilars, and other engineered constructs) shapes analytical strategy and method selection.
- Strong collaboration and alignment skills, with the ability to communicate findings clearly and maintain transparency with stakeholders.
- Experience mentoring junior scientists, guiding them in experimental design and problem-solving, and fostering a culture of rigorous science.
- Proactive problem-solving mindset, with the ability to apply analytical skills to address complex project challenges.
- Experience engaging across teams and functions, influencing decisions through effective data-driven communication.
- Excellent written and verbal communication skills.

We're fueled by a vision to transform biological engineering into a fully-fledged engineering discipline. Should you join our team, you will grow with a constantly evolving organization and push the frontiers of synthetic biology. Company culture is key to Asimov, and ours is a culture of recombination; we believe that our mission can only be achieved by bringing together a diverse team with a mixture of backgrounds and perspectives.

## About Asimov

## Company Overview
- **One-liner**: Asimov builds an integrated platform of cells, genes, and software to program living systems, enabling the design and manufacture of advanced therapies.
- **Entity Type**: Private (Series B, raised $175M in January 2023)
- **Headquarters**: Boston, Massachusetts, USA (with a second office in Boulder, Colorado)
- **Founded**: 2017
- **Founders**: Alec Nielsen (CEO), Chris Voigt, Doug Densmore, Raja Srinivas

## Core Business
- **Primary industry/industries**: Synthetic biology, biotechnology, therapeutics manufacturing
- **Target customers**: B2B – biotech startups, mid-size biotechs, and large pharmaceutical companies (partnered with over 25 companies)
- **Mission or purpose statement**: “To radically advance humanity’s ability to design living systems, enabling biological technologies with outsized societal benefit.”

## Products & Services
- **Design Software**: Cloud-based CAD platform to design, simulate, and optimize genetic systems in different cell types.
- **Genetic Parts Library**: Over 1,000 experimentally validated genetic parts (transposases, expression vectors, inducible systems, tissue-specific promoters, etc.).
- **Host Cell Lines**: Engineered, highly characterized GMP host cells for therapeutic production (CHO, HEK293, etc.) with regulatory documentation.
- **LV Edge**: Stable cell lines and software tools for lentiviral titers up to 1E9 TU/mL.
- **AAV Edge**: End-to-end payload design and production achieving titers up to 6E15 vg/L.
- **RNA Edge**: Sequence design through wet-lab validation in weeks.
- **CHO Edge**: Genetic tools and data-driven models delivering titers of 8–12 g/L across modalities.
- **Platform Transfer & Full Service**: Two engagement models – customers use the platform in-house, or Asimov performs cell line development and process development at its Boston lab.

## Market Standing
- **Valuation/Market Cap**: Not disclosed
- **Key Metric**: Total funding of $205M; annual revenue of ~$4.0M (LinkedIn estimate)
- **Notable Investors/Partners**: Andreessen Horowitz (seed lead), Horizons Ventures (Series A lead), CPP Investments (Series B lead), DARPA (research support). Partners include 25+ biotechs and pharma companies.
- **Growth Signals**: 95 employees (25.8% YoY growth); raised $200M in Series B (Jan 2023); launched AI-driven 4th generation CHO Edge System with increased titer guarantee; expanding into RNA and cell therapy tools.

## Competitive Advantages
- Only company offering an end-to-end platform that integrates mammalian synthetic biology, computer-aided design, and machine learning.
- Proprietary library of 1,000+ well-characterized genetic parts and GMP-banked host cells.
- “We use our own platform every day” – internal R&D teams validate improvements before releasing to customers.
- Strong regulatory support (GMP documentation for host cells) that de-risks therapeutic development.

## Strategic Focus
- Deepen AI/ML integration into genetic design and cell line development.
- Expand platform to cover more therapeutic modalities (cell therapy, RNA therapy, biologics).
- Scale partnerships with large pharma while continuing to support early-stage biotechs.
- Build out the “first CAD platform for biology” to transition genetic engineering into a fully-fledged engineering discipline.

## Why Work Here
- **Culture**: “A culture of recombination” – interdisciplinary team of biologists, engineers, and ML scientists. Values include mission first, urgency, continuous learning, thoughtful communication, and avoiding local optima.
- **Work model**: Hybrid – employees engage in a combination of remote and on-site work (Cambridge, MA and Boulder, CO).
- **Perks & growth**: Built In profile highlights career growth, compensation & benefits, work-life balance, and stability. The company is actively hiring across roles (Staff Software Engineer, Principal Scientist, Sr. Scientist, Associate Director).
- **Impact**: Work at the cutting edge of synthetic biology, directly contributing to the design and manufacture of life-saving therapies.

## Sources
1. [asimov.com](https://www.asimov.com/)
2. [asimov.com/about](https://www.asimov.com/about)
3. [LinkedIn](https://www.linkedin.com/company/asimov)
4. [Built In](https://builtin.com/company/asimov)
5. [Careers Page](https://jobs.ashbyhq.com/asimov)

## Other roles at Asimov

- [Scientist, Viral Vector Process Development](https://feeny.ai/job/scientist-viral-vector-process-development-asimov-boston-1qsqy03f8zyb) — Boston, MA
- [Scientist, Lentiviral Vector Cell Line Development](https://feeny.ai/job/scientist-lentiviral-vector-cell-line-development-asimov-boston-vhtpf4a8bt9m) — Boston, MA
- [Senior Scientist, Lentiviral Vector Cell Line Development](https://feeny.ai/job/senior-scientist-lentiviral-vector-cell-line-development-asimov-boston-fdjvx16748gc) — Boston, MA
- [Senior Program Manager](https://feeny.ai/job/senior-program-manager-asimov-boston-9pe8sjrfnxdw) — Boston, MA
- [Principal Scientist, Biologics Cell Line Development](https://feeny.ai/job/principal-scientist-biologics-cell-line-development-asimov-boston-zc098zf7xer4) — Boston, MA
- [Senior Scientist, Biologics Cell Line Development](https://feeny.ai/job/senior-scientist-biologics-cell-line-development-asimov-boston-5ypxr524ze78) — Boston, MA
- [Senior Scientist, Analytical Development](https://feeny.ai/job/senior-scientist-analytical-development-vaxcyte-san-carlos-zsgchcmsf98m) — San Carlos, CA
- [Senior Scientist, Analytical Development](https://feeny.ai/job/senior-scientist-analytical-development-seran-bioscience-bend-qh7wechq6zjv) — Bend, OR